Longitudinal Trends in Fluoroquinolone Resistance among Enterobacteriaceae Isolates from Inpatients and Outpatients, 1989--2000: Differences in the Emergence and Epidemiology of Resistance across Organisms

Lautenbach, Ebbing; Strom, Brian L.; nachamkin, Irving; Bilker, Waren B.; Marr, Ann Marie; larosa, Lori A.; Fishman, Neil O.
March 2004
Clinical Infectious Diseases;3/1/2004, Vol. 38 Issue 5, p655
Academic Journal
We conducted a 12-year study to identify and compare trends in annual prevalence of fluoroquinolone (FQ) resistance among Enterobacteriaceae isolates obtained from inpatients and outpatients in our health care system. A total of 46,070 clinical Enterobacteriaceae isolates underwent susceptibility testing. Although there were significant increases in inpatient FQ resistance for all Enterobacteriaceae, FQ resistance trends differed significantly across Enterobacteriaceae (P < .001). For isolates obtained from outpatients, only Escherichia coli and Proteus mirabilis demonstrated significant increases in FQ resistance (P < .001 for each). Trends in outpatient FQ resistance also differed significantly across Enterobacteriaceae (P < .001). There were significant differences between inpatient and outpatient FQ resistance trends for all Enterobacteriaceae except P. mirabilis and Enterobacter cloacae. Although hospital-wide use of certain antibiotics correlated significantly with inpatient FQ resistance, these correlations differed substantially across organisms. Efforts to elucidate the epidemiology of FQ resistance and identify targets for intervention must recognize and account for the variability of FQ resistance across organisms and clinical settings.


Related Articles

  • Novel variants of the Smqnr family of quinolone resistance genes in clinical isolates of Stenotrophomonas maltophilia. Gordon, N. C.; Wareham, D. W. // Journal of Antimicrobial Chemotherapy (JAC);Mar2010, Vol. 65 Issue 3, p483 

    Background: Recent analysis of Stenotrophomonas maltophilia has identified a novel family of resistance genes (Smqnr) encoding pentapeptide repeat proteins, which confer low-level resistance to quinolones. This study describes further novel variants present in clinical isolates of S. maltophilia...

  • Impact of Fluoroquinolone Administration on the Emergence of Fluoroquinolone-Resistant Gram-Negative Bacilli from Grastrointestinal Flora. Richard, Pascale; Delangle, Marie Helene; Raffi, Francois; Espaze, Eric; Richet, Herve // Clinical Infectious Diseases;1/1/2001, Vol. 32 Issue 1, p162 

    Discusses a study which assessed the risk factors for acquisition of fluoroquinolone-resistant, gram-negative organisms in the gastrointestinal tract of hospitalized patients. Use of fluoroquinolone for the treatment of infections; Methods used; Analysis of risk factors for colonization with...

  • Fluoroquinolones: How to use (but not overuse) these antibiotics. Sable, Carole A.; Scheld, W. Michael // Geriatrics;Jun1993, Vol. 48 Issue 6, p41 

    The fluoroquinolone antibiotics are relatively new agents with long serum half lives, a high degree of bioavailability, and a broad spectrum of activity against many gram-negative and some gram-positive organisms. They are useful in a range of clinical settings but should not be considered as...

  • Effect of Quinolones on Intestinal Ecology. Edlund, C.; Nord, C.E. // Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p65 

    Quinolones have a selective effect on the normal human intestinal microflora. Published data on 13 different quinolone agents [ciprofloxacin, enoxacin, norfloxacin, ofloxacin, pefloxacin, lomefloxacin, levofloxacin, sparfloxacin, rufloxacin, sitafloxacin (DU-6859a), gatifloxacin, trovafloxacin...

  • Impact of a fluoroquinolone formulary change on acquisition of quinolone-resistant gram-negative bacilli. Hota, B. N.; Pur, S.; Phillips, L.; Weinstein, R. A.; Segreti, J. // European Journal of Clinical Microbiology & Infectious Diseases;Jun2005, Vol. 24 Issue 6, p405 

    Rising rates of fluoroquinolone resistance in bacteria have been associated with increased fluoroquinolone use. In vitro data show differences in potency among fluoroquinolone antibiotics against gram-negative bacteria and have led to the hypothesis that rates of selection of resistant...

  • Susceptibility of Stenotrophomonas maltophilia to Moxifloxacin, Trovafloxacin, Ofloxacin and Ciprofloxacin. Hawley, H.B.; Polenakovik, H.M.; Czachor, J.S.; Mueller, S.S. // Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p214 

    Examines the in vitro susceptibility of clinical isolates of Gram-negative bacterium Stenotrophomonas maltophilia to newer quinolones. Materials and methods; Results.

  • Human Salmonella and concurrent decreased susceptibility to quinolones and extended-spectrum cephalosporins. Whichard, Jean M.; Gay, Kathryn; Stevenson, Jennifer E.; Joyce, Kevin J.; Cooper, Kara L.; Omondi, Michael; Medalla, Felicita; Jacoby, George A.; Barrett, Timothy J. // Emerging Infectious Diseases;Nov2007, Vol. 13 Issue 11, p1681 

    The National Antimicrobial Resistance Monitoring System monitors susceptibility among Enterobacteriaceae in humans in the United States. We studied isolates exhibiting decreased susceptibility to quinolones (nalidixic acid MIC >32 microg/mL or ciprofloxacin MIC > or =0.12 microg/mL) and...

  • Unexpected Occurrence of Plasmid-mediated Quinolone Resistance Determinants in Environmental Aeromonas spp. Cattoir, Vincent; Poirel, Laurent; Aubert, Camille; Soussy, Claude-James; Nordmann, Patrice // Emerging Infectious Diseases;Feb2008, Vol. 14 Issue 2, p231 

    We searched for plasmid-mediated quinolone resistance determinants of the Qnr type in several water samples collected at diverse locations from the Seine River (Paris, France). The qnrS2 genes were identified from Aeromonas punctata subsp. punctata and A. media. The qnrS2 gene was located on...

  • Trends in production of extended-spectrum β-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals. Rodriguez-Villalobos, H.; Bogaerts, P.; Berhin, C.; Bauraing, C.; Deplano, A.; Montesinos, I.; de Mendonça, R.; Jans, B.; Glupczynski, Y. // Journal of Antimicrobial Chemotherapy (JAC);Jan2011, Vol. 66 Issue 1, p37 

    Objectives To assess the frequency and diversity of extended-spectrum β-lactamases (ESBLs) in Enterobacteriaceae isolates in Belgium. Methods During 2006 and 2008, non-duplicate clinical isolates of Enterobacteriaceae resistant to ceftazidime and/or cefotaxime were collected in 100 Belgian...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics